STOCK TITAN

AnaptysBio (ANAB) awards CEO 53,334 performance stock units

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Faga Daniel reported acquisition or exercise transactions in this Form 4 filing.

AnaptysBio, Inc. reported that President and CEO Daniel Faga received a grant of 53,334 performance stock units (PSUs), each representing one share of common stock. The PSUs were earned based on certified performance criteria and vest over two years: 50% on March 12, 2027 and 50% on March 12, 2028, subject to his continued service.

Positive

  • None.

Negative

  • None.
Insider Faga Daniel
Role President, CEO
Type Security Shares Price Value
Grant/Award Performance Stock Units F1, F2, F3 53,334 $0.00 $0.00
Holdings After Transaction: Performance Stock Units — 53,334 shares (Direct)
Footnotes (3)
  1. F1. Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on March 12, 2026.
  2. F2. Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.
  3. F3. The PSUs vest and settle over two years; 50% vests on March 12 2027 and 50% vests on March 12, 2028, subject to the continuing service of the Reporting Person on each vesting date.
Performance stock units granted 53334.0000 units Grant to President and CEO Daniel Faga on March 12, 2026
Underlying common shares 53334.0000 shares Each PSU represents one share of common stock upon settlement
Transaction price per unit $0.0000 Grant, award, or other acquisition of performance stock units
Vesting on March 12 2027 50 % First half of PSUs vests and settles on March 12 2027
Vesting on March 12, 2028 50 % Second half of PSUs vests and settles on March 12, 2028
Performance Stock Units financial
"Represents performance-based restricted stock units ("PSUs") that were earned"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
restricted stock units financial
"Represents performance-based restricted stock units ("PSUs") that were earned"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Compensation Committee financial
"performance criteria as certified by the Compensation Committee of the Issuer's Board"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
vest and settle financial
"The PSUs vest and settle over two years; 50% vests on March 12 2027"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did AnaptysBio (ANAB) CEO Daniel Faga report in this Form 4 filing?

Daniel Faga reported receiving a grant of 53,334 performance stock units (PSUs) from AnaptysBio. These units were earned after meeting specified performance criteria and convert into common stock as they vest over two years, subject to his continued service.

How many performance stock units were granted to ANAB CEO Daniel Faga?

Daniel Faga was granted 53,334 performance stock units. Each PSU represents a conditional right to receive one share of AnaptysBio common stock, giving him potential future equity if the units vest according to the specified schedule and service conditions.

When do the performance stock units for AnaptysBio (ANAB) CEO vest?

The PSUs vest and settle over two years: 50% on March 12, 2027 and 50% on March 12, 2028. Vesting is conditioned on Daniel Faga’s continued service with AnaptysBio on each vesting date.

What does each performance stock unit represent for AnaptysBio (ANAB)?

Each PSU represents a conditional right to receive one share of AnaptysBio common stock. Shares are delivered only when units vest and settle, tying executive compensation to both performance and continued service.

Were the ANAB CEO’s performance stock units tied to performance criteria?

Yes. The 53,334 PSUs were earned after achievement of specified performance criteria, as certified by AnaptysBio’s Compensation Committee on March 12, 2026. This links the award directly to company performance before the vesting schedule applies.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Faga Daniel

(Last)(First)(Middle)
C/O ANAPTYSBIO, INC.
10770 WATERIDGE CIRCLE, SUITE 210

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ANAPTYSBIO, INC [ ANAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President, CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Stock Units(1)(2)03/12/2026A53,334 (3) (3)Common Stock53,334$053,334D
Explanation of Responses:
1. Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on March 12, 2026.
2. Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.
3. The PSUs vest and settle over two years; 50% vests on March 12 2027 and 50% vests on March 12, 2028, subject to the continuing service of the Reporting Person on each vesting date.
/s/ Christopher Murphy, Attorney-in-Fact08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)